MOdeling of human anti-GBM antibody-α3(IV)NC1 interactions Predicts antigenic cross-linking through contact of both heavy chains with repeating epitopes on α3(IV)NC1

American Journal of Nephrology

Volumn 30, Issue 5, 2009, Pages 474-480

  Meyers, Kevin E C ^a,b   Christensen, Mette ^a,b   Madaio, Michael P ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

3(IV) collagen; Anti glomerular basement membrane disease; Glomerulonephritis

Indexed keywords

EPITOPE; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; TUMSTATIN;

ANIMAL EXPERIMENT; ANTIGEN BINDING; ANTIGEN STRUCTURE; ARTICLE; CONTROLLED STUDY; CROSS REACTION; GENE SEQUENCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN PROTEIN INTERACTION;

ANIMALS; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY REACTIONS; AUTOANTIBODIES; AUTOANTIGENS; BINDING SITES; COLLAGEN TYPE IV; CROSS-LINKING REAGENTS; DISEASE MODELS, ANIMAL; EPITOPES; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; MICE; MICE, TRANSGENIC; MODELS, CHEMICAL; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY;

EID: 70349428926     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000242476     Document Type: Article

References (23)

1. Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG: Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Eng J Med 2003; 348: 2543-2556.
2. Meyers KE, Kinniry PA, Kalluri R, Neilson EG, Madaio MP: Human Goodpasture antialpha3( IV)NC1 autoantibodies share structural determinants. Kidney Int 1998; 53: 402-407.
3. Rutgers A, Meyers KE, Canziani G, Kalluri R, Lin J, Madaio MP: High affinity of anti-GBM antibodies from Goodpasture and transplanted Alport patients to alpha3(IV)NC1 collagen. Kidney Int 2000; 58 : 115-122.
4. Fawzi A, Robinet A, Monboisse JC, Ziaie Z, Kefalides NA, Bellon G: A peptide of the alpha 3 (IV) chain of type IV collagen modulates stimulated neutrophil function via activation of cAMP-dependent protein kinase and Ser/Thr protein phosphatase. Cell Signal 2000 ; 12: 327-335.
5. Kalluri R, Weber M, Netzer KO, Sun MJ, Neilson EG, Hudson BG: COL4A5 gene deletion and production of post-transplant antialpha 3 (IV) collagen alloantibodies in Alport syndrome. Kidney Int 1994; 45: 721-726.
6. Netzer KO, Leinonen A, Boutaud A, Borza DB, Todd P, Gunwar S, Langeveld JP, Hudson BG: The goodpasture autoantigen. Mapping the major conformational epitope(s) of alpha3(IV) collagen to residues 17-31 and 127 -141 of the NC1 domain. J Biol Chem 1999 ; 274: 11267-11274.
7. Kalluri R, Torre A, Shield CF 3rd, Zamborsky ED, Werner MC, Suchin E, Wolf G, Helmchen UM, van den Heuvel LP, Grossman R, Aradhye S, Neilson EG: Identification of alpha3, alpha4, and alpha5 chains of type IV collagen as alloantigens for Alport posttransplant anti-glomerular basement membrane antibodies. Transplantation 2000 ; 69: 679-683.
8. Cleveland DW, Fischer SG, Kirschner MW, Laemmli UK: Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis. J Biol Chem 1977 ; 252: 1102-1106.
9. Borza DB, Bondar O, Todd P, Sundaramoorthy M, Sado Y, Ninomiya Y, Hudson BG: Quaternary organization of the goodpasture autoantigen, the alpha 3(IV) collagen chain. Sequestration of two cryptic autoepitopes by intrapromoter interactions with the alpha4 and alpha5 NC1 domains. J Biol Chem 2002; 277 : 40075-40083.
10. Meyers KE, Allen J, Gehret J, Jacobovits A, Gallo M, Neilson EG, Hopfer H, Kalluri R, Madaio MP: Human antiglomerular basement membrane autoantibody disease in XenoMouse II. Kidney Int 2002; 61: 1666-1673 , comment 1905-1906.
11. Lin J, Yanase K, Rutgers A, Madaio MP, Meyers KE: Selection of specific phage from display libraries: Monoclonal antibody against VCS M13 helper phage coat protein III (gIIIp). Hybridoma 1999; 18: 257-261.
12. Harrison JL, Williams SC, Winter G, Nissim A: Screening of phage antibody libraries. Methods Enzymol 1996; 267: 83-109. (Pubitemid 26159217)
13. Schwede T, Kopp J, Guex N, Peitsch MC: SWISS-MODEL: An automated protein homology- modeling server. Nucleic Acids Res 2003 ; 31: 3381-3385.
14. Guex N, Peitsch MC: SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling. Electrophoresis 1997 ; 18: 2714-2723.
15. Peitsch MC: Protein modeling by E-mail. Bio/Technology 1995; 13: 658-660.
16. Martin AC, Cheetham JC, Rees AR: Modelling antibody hypervariable loops: A combined algorithm. Proc Natl Acad Sci USA 1989 ; 86: 9268-9272.
17. Martin ACR, Cheetham JC, Rees AR: Molecular modelling of antibody combining sites. Methods Enzymol 1991;203:121-153.
18. Pedersen JT et al: Antibody modelling: Beyond homology. Immunomethods 1992;1: 126-136.
19. Rees AR, et al: Antibody combining sites: Structure and prediction; in Sternberg MJE (ed): Protein Structure Prediction. New York, Oxford University Press, 1996, pp 141-172.
20. Whitelegg NRJ, Rees AR: WAM - an improved algorithm for modelling antibodies on the Web. Protein Eng 2000;13:819-824.
21. Kalluri R, et al: COL4A5 gene deletion and production of post-transplant anti-alpha 3 (IV) collagen alloantibodies in Alport syndrome. Kidney Int 1994;45:721-726.
22. Kalluri R, et al: Identification of alpha3, alpha4, and alpha5 chains of type IV collagen as alloantigens for Alport posttransplant anti-glomerular basement membrane antibodies. Transplantation 2000;69:679-683.
23. Ooi JD, Holdsworth SR, Kitching AR: Advances in the pathogenesis of Goodpasture's disease: From epitopes to autoantibodies to effector T cells. J Autoimmun 2008;31: 295-300.